Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
Healthtrust
Cipla
QuintilesIMS
Cerilliant
Julphar
Federal Trade Commission
Citi
Covington

Generated: October 17, 2017

DrugPatentWatch Database Preview

Paddock Llc Company Profile

« Back to Dashboard

What is the competitive landscape for PADDOCK LLC, and what generic and branded alternatives to PADDOCK LLC drugs are available?

PADDOCK LLC has forty-seven approved drugs.



Summary for Applicant: Paddock Llc

US Patents:0
Tradenames:43
Ingredients:39
NDAs:47
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
CLINDA-DERM
clindamycin phosphate
SOLUTION;TOPICAL063329-001Sep 30, 1992ATRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
CLINDAMYCIN PALMITATE HYDROCHLORIDE
clindamycin palmitate hydrochloride
FOR SOLUTION;ORAL090902-001Jul 7, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
BROMFENAC SODIUM
bromfenac sodium
SOLUTION/DROPS;OPHTHALMIC201941-001Feb 10, 2015AT1RXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
POTASSIUM CHLORIDE
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL200185-001May 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
MIDAZOLAM HYDROCHLORIDE
midazolam hydrochloride
SYRUP;ORAL076379-001May 2, 2005AARXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
POLYETHYLENE GLYCOL 3350
polyethylene glycol 3350
FOR SOLUTION;ORAL077893-001May 26, 2006AARXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
MIDAMOR
amiloride hydrochloride
TABLET;ORAL018200-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Paddock Llc
BACITRACIN
bacitracin
POWDER;FOR RX COMPOUNDING062456-001Jul 27, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
POLYMYXIN B SULFATE
polymyxin b sulfate
POWDER;FOR RX COMPOUNDING062455-001Jul 27, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
REPAGLINIDE
repaglinide
TABLET;ORAL201189-001Jul 17, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Healthtrust
Baxter
Boehringer Ingelheim
Fish and Richardson
Teva
Moodys
Merck
Queensland Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot